Cannabichromene (CBC) is one of the principal non-psychoactive cannabinoids found in the cannabis plant. Often overlooked in favor of THC and CBD, CBC reveals unique therapeutic properties and acts synergistically in the cannabinoid spectrum. It is considered a key player in the entourage effect, amplifying the actions of other cannabinoids and terpenes, and contributes to the full-spectrum therapeutic profile of cannabis.
CBC’s molecular formula is C₂₁H₃₀O₂, with a molar mass of approximately 314.47 g/mol. Structurally, CBC is classified as a neutral cannabinoid, formed via decarboxylation of CBCA. Its core features a chromene backbone, which differentiates it from the more common pentyl-phenol skeletons of THC and CBD. CBC typically presents as a colorless to yellowish oil, with a boiling point around 220 °C.
CBC does not bind strongly to CB₁ receptors and is non-psychoactive. However, it demonstrates moderate affinity for CB₂ receptors and acts as an agonist at TRPA1, TRPV1, TRPV3, and TRPV4 ion channels. These interactions underlie its anti-inflammatory, analgesic, and neuroprotective effects. CBC also appears to promote neurogenesis and may modulate the endocannabinoid system by influencing anandamide uptake and breakdown.
CBC is under investigation for its anti-inflammatory, pain-relieving, antidepressant, and antifungal effects. Preclinical studies suggest potential utility in the treatment of neuropathic pain, mood disorders, acne, and neurodegenerative conditions. While not yet an approved medicine, CBC is present in full-spectrum cannabis extracts and is valued for its contribution to whole-plant synergy.
CBC is non-intoxicating and generally well-tolerated, with no acute toxicity reported. Its main limitations include low bioavailability and sensitivity to light and oxygen, which may affect stability in extracts and products. Clinical evidence remains limited, and high-purity CBC is still difficult to isolate at scale.
🌿 Bridge — Connector in the cannabinoid network, enabling synergy
🧬 Resonator — Amplifies the actions of other molecules
💡 Spark — Ignites neurogenesis and innovation in therapeutic design
Emerging fields of study include CBC’s role in neural regeneration, its combinatory effect in the entourage spectrum, and its possible impact on skin health and chronic inflammatory diseases. Interest is also growing in its potential for mood modulation and as a co-therapeutic in multi-cannabinoid medicine.
CBC stands as a subtle but vital force within the cannabis pharmacological tree. Its lack of psychoactivity is balanced by a powerful contribution to whole-plant effects, especially through synergistic interactions. As research continues, CBC may reveal new therapeutic pathways and reinforce the unique complexity of cannabis as a multi-dimensional medicine.
We never did this for the money.
We did it because molecules tell stories—stories that bridge healing, curiosity, and responsibility across cultures and generations.
If you feel this work holds value and wish to be part of sustaining independent research, you are warmly invited to stand with us.
🟢 Disclaimer
The information provided on this website is intended solely for general informational and educational purposes related to the scientific analysis and classification of medical cannabis data. It does not constitute medical advice, diagnosis, or treatment recommendations and should not be used as a substitute for professional medical consultation.
All content has been sourced from our proprietary database and is systematically processed, structured, and formatted through our middleware systems. A final validation is performed using a combination of algorithmic quality assurance procedures and editorial review.
While we strive to ensure the highest level of accuracy, completeness, and currency, we make no guarantees regarding the reliability or applicability of the information provided. For any questions related to health, treatment decisions, or the use of medical cannabis, please consult a qualified healthcare professional.
Maria-Theresia-Str. 11
81675 Munich
Germany
